Christophe Beauloye

机构：Cliniques Universitaires Saint-Luc, Directorate-General Joint Research Centre, UCLouvain · ORCID：0000-0002-1665-8267

发表论文 352 篇 · 总被引 9941 次 · h-index 56

代表论文

• Carbohydrate Antigen 125: A Useful Marker of Congestion, Fibrosis, and Prognosis in Heart Failure with Preserved Ejection Fraction (2024 · ESC Heart Failure · 被引 28)
• Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES (2025 · Circulation · 被引 25)
• Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation (2024 · European Heart Journal - Cardiovascular Pharmacotherapy · 被引 25)
• Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project (2024 · EBioMedicine · 被引 22)
• Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction (2025 · Cardiovascular Diabetology · 被引 19)
• Fibroblasts and platelets: a face-to-face dialogue at the heart of cardiac fibrosis (2024 · American Journal of Physiology-Heart and Circulatory Physiology · 被引 12)